Designating July 15, 2026, as “Glioblastoma Awareness Day”.

designates July 15, 2026, as “Glioblastoma Awareness Day”;

encourages increased public awareness of glioblastoma;

honors the individuals who have died from the devastating disease of glioblastoma or are currently living with the disease;

supports efforts to develop better treatments for glioblastoma that will improve the long-term prognosis for, and the quality of life of, individuals diagnosed with the disease;

recognizes the importance of molecular biomarker testing to the diagnosis and treatment of glioblastoma;

expresses support for the individuals who are battling brain tumors, as well as the families, friends, and caregivers of those individuals;

urges a collaborative approach to brain tumor research among governmental, private, and nonprofit organizations, which is a promising means of advancing the understanding and treatment of glioblastoma; and

encourages continued investments in glioblastoma research and treatments, including through the Glioblastoma Therapeutics Network and other existing brain tumor research resources.